Korelacija indeksa telesne težine i ortostatske hipotenzije kod hipertenzivnih bolesnika na monoterapiji ACE inhibitorima

  • Danijela Tasić Cardiovascular Institute Dedinje, Belgrade, Serbia; Faculty of medicine, University of Banjaluka, RS
  • Zorana Kovačević Cardiovascular Institute Dedinje, Belgrade, Serbia
  • Miroslav Mitrović Hypertension, Infarction, Stroke, Prevention Association, Serbia
  • Zlatko Maksimović General Hospital "Sveti Vračevi", Bijeljina, RS
  • Dragana Lončar-Stojiljković Cardiovascular Institute Dedinje, Belgrade, Serbia; Faculty of medicine, University of Banjaluka, RS
  • Nebojša Tasić
DOI: https://doi.org/10.5937/scriptamed52-32561
Ključne reči: Ortostatska hipotenzija, Trandolapril, Indeks tjelesne mase

Sažetak


Background/Aim: Orthostatic hypotension (OH) is considered to be a drop in the systolic and diastolic blood pressure (> 20 mmHg; > 10 mmHg) 3 minutes from postural changes. The objective of this study was to analyse the correlation of body mass index (BMI) and OH during the treatment with trandolapril, as a single-drug treatment of hypertension.

Methods: The study involved 255 patients (average age 54.3 ± 11.7; 54.1 % men) with poorly regulated hypertension, who were given trandolapril as a single-drug treatment. The patients were divided into two groups regarding stage of hypertension: first-degree arterial hypertension (140-149 mmHg for systolic and 90-109 mmHg for diastolic blood pressure) and second-degree arterial hypertension (> 150 for systolic and > 110 mmHg for diastolic blood pressure). Incidence of OH occurrence was then analysed regarding hypertension stage and BMI during 6 months of follow-up, on 4 control examinations.

Results: During 24-week period after trandolapril introduction into the treatment of hypertension, a statistically significant difference in systolic, diastolic and mean blood pressure values was observed. No statistically significant difference was observed in incidence of OH between the first and second as well as between third and fourth examination during the study. Regarding the incidence of OH in normal body weight and obese patients, there was also no statistically significant difference.

Conclusion: As shown in this study, trandolapril, along with some other ACE inhibitors, has shown good balance in hypertension control and OH occurrence.

Reference

Fatima S, Noor S, Fatima A, Maazuddin M. A review on importance of ACE inhibitors in clinical practice. Med Res Chron 2014;1(1):102-9.

Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013 Jul;31(7):1281-357.

Wiseman LR, McTavish D. Trandolapril. A review of its pharmacodynamics and pharmacokinetic properties, and therapeutic use in essential hypertension. Drugs 1994;48:71–90.

Freeman R. Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med 2008 Feb 7;358(6):615-24.

Low PA. Prevalence of orthostatic hypotension. Clin Auton Res 2008 Mar;18 Suppl 1:8-13.

Gupta V, Lipsitz LA. Orthostatic hypotension in the elderly: diagnosis and treatment. Am J Med 2007;120:841-7.

Zia A, Kamaruzzaman SB, Tan MP. Blood pressure lowering therapy in older people: Does it really cause postural hypotension or falls? Postgrad Med 2015 Mar;127(2):186-93.

Shibao C, Lipsitz LA, Biaggioni I. ASH position paper: evaluation and treatment of orthostatic hypotension. J Clin Hypertens (Greenwich) 2013 Mar;15(3):147-53.

Low PA, Tomalia VA. Orthostatic hypotension: mechanisms, causes, management. J Clin Neurol 2015 Jul;11(3):220-6.

Maser RE, Lenhard MJ. An overview of the effect of weight loss on cardiovascular autonomic function. Curr Diabetes Rev 2007 Aug;3(3):204-11.

Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003;26:1553-79.

Karason K, Molgaard H, Wikstrand J, Sjostrom L. Heart rate variability in obesity and the effect of weight loss. Am J Cardiol 1999;83:1242-7.

Emdin M, Gastaldelli A, Muscelli E, Macerata A, Natali A, Camastra S, et al. Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss. Circulation 2001 Jan 30;103(4):513-9.

Lascano CA, Szomstein S, Zundel N, Rosenthal RJ. Diabetes mellitus-associated diffuse autonomic dysfunction causing debilitating hypotension manifested after rapid weight loss in a morbidly obese patient: case report and review of the literature. Surg Obes Relat Dis 2005 Jul-Aug;1(4):443-6.

Hoeldtke RD, Dworkin GE, Gaspar SR, Israel BC. Sympathotonic orthostatic hypotension: a report of four cases. Neurology 1989 Jan;39(1):34-40.

Rubinshtein R, Ciubotaru M, Elad H, Bitterman H. Severe orthostatic hypotension following weight reduction surgery. Arch Intern Med 2001 Sep 24;161(17):2145-7.

Lahrmann H, Cortelli P, Hilz M, Mathias CJ, Struhal W, Tassinari M. Orthostatic hypotension. In: Gilhus NE, Barnes MP, Brainin M, editors. European handbook of neurological management. Volume 1, 2nd edition. Hoboken, New Jersey, USA: Blackwell Publishing Ltd; 2011. p. 469-75.

Davy KP, Seals DR, Tanaka H. Augmented cardiopulmonary and integrative sympathetic baroreflexes but attenuated peripheral vasoconstriction with age. Hypertension 1998;32:298–304.

Rutan GH, Hermanson B, Bild DE, Kittner SJ, LaBaw F, Tell GS. Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension 1992 Jun;19(6 Pt 1):508-19.

Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 2011 Apr;21(2):69-72.

Fedorowski A, Stavenow L, Hedblad B, Berglund G, Nilsson PM, Melander O. Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project). Eur Heart J 2010;31:85–91.

Eigenbrodt ML, Rose KM, Couper DJ, Arnett DK, Smith R, Jones D. Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke 2000 Oct;31(10):2307-13.

Kamaruzzaman S, Watt H, Carson C, Ebrahim S. The association between orthostatic hypotension and medication use in the British Women’s Heart and Health Study. Age Ageing 2010 Jan;39(1):51–6.

Canney M, O'Connell MD, Murphy CM, O'Leary N, Little MA, O'Seaghdha CM, et al. Single agent antihypertensive therapy and orthostatic blood pressure behaviour in older adults using beat-to-beat measurements: The Irish longitudinal study on ageing. PLoS One 2016 Jan 5;11(1):e0146156.

Montastruc JL, Laborie I, Bagheri H, Senard JM. Drug-induced orthostatic hypotension: a five-year experience in a regional pharmacovigilance centre in France. Clin Drug Invest 1997;14(1):61-5.

Furlan R, Jacob G, Snell M, Robertson D, Porta A, Harris P, et al. Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control. Circulation 1998 Nov 17;98(20):2154-9.

De Ponti F, Marelli C, D'Angelo L, Caravaggi M, Bianco L, Lecchini S, et al. Pharmacological activity and safety of trandolapril (RU 44570) in healthy volunteers. Eur J Clin Pharmacol 1991;40(2):149-53.

Li X, Liu C, Wu M, Zhang H, Sun Y, Cheng L, et al. Pharmacokinetics, pharmacodynamics, and tolerability of single and multiple doses of trandolapril, an effective angiotensin-converting enzyme inhibitor, in healthy Chinese subjects. Eur J Drug Metab Pharmacokinet 2016 Aug;41(4):373-84.

Objavljeno
2021/06/29
Broj časopisa
Vol. 52 Br. 2 (2021): Q2/June
Rubrika
Originalni naučni članak
Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).